Evidence map›Paper›PMID 36876754›Full record

ArticleThe New England journal of medicine2023

Electronic Prior Authorization for Prescription Drugs - Challenges and Opportunities for Reform.

Jing Luo, Walid F Gellad

Abstract read
In one paragraph

Article in The New England journal of medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Computer-Assisted Clinical Diagnosis and Treatment.Current allergy and asthma reports · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Jing LuoFrom the Division of General Internal Medicine, Department of Medicine, University of Pittsburgh School of Medicine (J.L., W.F.G.), and the Center for Health Equity Research and Promotion, VA Pittsburgh Healthcare System (W.F.G.) - both in Pittsburgh.
Walid F GelladFrom the Division of General Internal Medicine, Department of Medicine, University of Pittsburgh School of Medicine (J.L., W.F.G.), and the Center for Health Equity Research and Promotion, VA Pittsburgh Healthcare System (W.F.G.) - both in Pittsburgh.

Funding

Developing a provider-facing intervention to address cost-related medication restrictions and improve medication use in patients with type 2 diabetesK23DK120956 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI LUO, JING · 2021 to 2024
$829k
NIDDK NIH HHS K23 DK120956
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Electronic PrescribingHealth Care ReformPrescription DrugsPrior AuthorizationHumansInsurance, Pharmaceutical ServicesMedical Records Systems, ComputerizedUnited StatesPrescription Drugs

Identifiers

PMID36876754
PMCPMC10880819

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.